Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Chiral Materials: Progress, Applications, and Prospects
Xiaohui Niu, Rui Zhao, Simeng Yan, et al.
Small (2023) Vol. 19, Iss. 38
Closed Access | Times Cited: 64
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C
Tatiana Brémovà-Ertl, Jens Claaßen, Tomas Foltan, et al.
Journal of Neurology (2021) Vol. 269, Iss. 3, pp. 1651-1662
Open Access | Times Cited: 43
N-Acetyl-l-leucine improves functional recovery and attenuates cortical cell death and neuroinflammation after traumatic brain injury in mice
Nivedita Hegdekar, Marta M. Lipinski, Chinmoy Sarkar
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 37
N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
Taylor Fields, Tatiana Brémovà-Ertl, Ian Billington, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Efficacy and Safety of N-Acetyl- l -Leucine in Children and Adults With GM2 Gangliosidoses
Κyriakos Martakis, Jens Claaßen, Jordi Gascon-Bayari, et al.
Neurology (2022) Vol. 100, Iss. 10
Open Access | Times Cited: 22
Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications
Jan Cendelín, Marija Cvetanović, Mandi Gandelman, et al.
The Cerebellum (2021) Vol. 21, Iss. 3, pp. 452-481
Open Access | Times Cited: 24
Acetylation turns leucine into a drug by membrane transporter switching
Grant C. Churchill, Michael Strupp, Cailley Factor, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
SIMPATHIC: Accelerating drug repurposing for rare diseases by exploiting SIMilarities in clinical and molecular PATHology
Clara van Karnebeek, Annelieke R. Müller, Laura Benkemoun, et al.
Molecular Genetics and Metabolism (2025) Vol. 144, Iss. 4, pp. 109073-109073
Closed Access
Phenotype assessment for neurodegenerative murine models with ataxia and application to Niemann–Pick disease, type C1
Julia C. Yerger, Antony Cougnoux, Craig B. Abbott, et al.
Biology Open (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 16
Current advancements in therapy for Niemann-Pick disease: progress and pitfalls
Tatiana Brémovà-Ertl, Susanne A. Schneider
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 11, pp. 1229-1247
Closed Access | Times Cited: 9
Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies
Julie Lekstrom‐Himes, Philip J. Brooks, Dwight D. Koeberl, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2023) Vol. 193, Iss. 1, pp. 30-43
Open Access | Times Cited: 8
Pharmacological Profile of FDA-Approved Orphan Drugs in the Year 2022
Parveen Kumar Goyal, Kavita Sangwan
Current Pharmacology Reports (2024) Vol. 10, Iss. 2, pp. 96-120
Closed Access | Times Cited: 3
Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial
Mehran Beyraghi‐Tousi, Amirhosein Sahebkar, Mahsa Houra, et al.
European Journal of Paediatric Neurology (2024) Vol. 50, pp. 57-63
Closed Access | Times Cited: 2
Assessment of the reliability, responsiveness, and meaningfulness of the scale for the assessment and rating of ataxia (SARA) for lysosomal storage disorders
Julien H. Park, Tatiana Brémovà-Ertl, Marion M. Brands, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 6888-6902
Open Access | Times Cited: 2
Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome
K. Kühn, Howard M. Lederman, Sharon A. McGrath‐Morrow
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 693-704
Open Access | Times Cited: 6
The Effect of N-Acetyl-DL-Leucine on Neurological Symptoms in a Patient with Ataxia-Telangiectasia: a Case Study
Maryam Saberi‐Karimian, Mehran Beyraghi‐Tousi, Mansoureh Mirzadeh, et al.
The Cerebellum (2022) Vol. 22, Iss. 1, pp. 96-101
Closed Access | Times Cited: 8
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias
Marie Beaudin, Nicolas Dupré, Mario Manto
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 9, pp. 897-912
Closed Access | Times Cited: 1
Loss of Flot2 expression in deep cerebellar nuclei neurons of mice with Niemann-Pick disease type C
Tsu-I Chen, Pei-Chun Hsu, Ni‐Chung Lee, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18082-e18082
Open Access | Times Cited: 3
Pharmacological Treatment of Acute Unilateral Vestibulopathy: A Review
Francisco Alves de Sousa, Clara Serdoura Alves, Ana Nóbrega Pinto, et al.
Journal of Audiology & Otology (2023) Vol. 28, Iss. 1, pp. 18-28
Open Access | Times Cited: 3
Ataxia Telangiectasia
Robert A. Dineen, William Whitehouse
Springer eBooks (2023), pp. 621-630
Closed Access | Times Cited: 2
Pharmacotherapy of cerebellar and vestibular disorders
João Lemos, Mario Manto
Current Opinion in Neurology (2021) Vol. 35, Iss. 1, pp. 118-125
Closed Access | Times Cited: 5
Assessment of the Reliability, Responsiveness, and Meaningfulness of the Scale for the Assessment and Rating of Ataxia (SARA) for Lysosomal Storage Disorders
Julien H. Park, Tatiana Brémovà-Ertl, Marion M. Brands, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Latest Developments for the Treatment of Ataxia Telangiectasia: A Narrative Review
Ali Mehri, Mehran Beiraghi Toosi, Ali Reza Tavasoli, et al.
The Cerebellum (2024)
Closed Access
Pioglitazone as a Possible Treatment for Ataxia-Telangiectasia
Rodney E. Shackelford
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1264-1264
Open Access
Clinical and molecular findings in Ataxia–Telangiectasia
Shuki Mizutani, Domenico Delia
Elsevier eBooks (2024), pp. 127-132
Closed Access
Page 1 - Next Page

Scroll to top